Deutsche Bank Maintains Buy on Universal Health Servs, Lowers Price Target to $145
Deutsche Bank analyst Pito Chickering maintains Universal Health Servs (NYSE:UHS) with a Buy and lowers the price target from $168 to $145.
Mizuho Maintains Buy on Universal Health Servs, Lowers Price Target to $140
Mizuho analyst Ann Hynes maintains Universal Health Servs (NYSE:UHS) with a Buy and lowers the price target from $144 to $140.
UBS Upgrades Universal Health Services to Neutral, Raises Price Target to $167
UBS analyst Andrew Mok upgrades Universal Health Services (NYSE:UHS) from Sell to Neutral and raises the price target from $113 to $167.
Barclays Maintains Underweight on Universal Health Services, Raises Price Target to $132
Barclays analyst Steve Valiquette maintains Universal Health Services (NYSE:UHS) with a Underweight and raises the price target from $115 to $132.
Universal Health Services, Madrigal Pharmaceuticals And These Overbought Majors In The Healthcare Sector
The most overbought stocks in the healthcare sector presents an opportunity to go short on these overvalued companies.
Mizuho Maintains Buy on Universal Health Services, Raises Price Target to $144
Mizuho analyst Ann Hynes maintains Universal Health Services (NYSE:UHS) with a Buy and raises the price target from $126 to $144.
Universal Health Services To Rally Around 25%? Here Are 5 Other Price Target Changes For Friday
Credit Suisse raised Universal Health Services, Inc. (NYSE: UHS) price target from $129 to $157. Credit Suisse analyst Jonathan Yong maintained an Outperform rating on the stock. Universal Health fell 2.7% to $126.15 in pre-market trading.
SVB Leerink Maintains Market Perform on Universal Health Services, Raises Price Target to $114
SVB Leerink analyst Whit Mayo maintains Universal Health Services (NYSE:UHS) with a Market Perform and raises the price target from $98 to $114.
Why New Oriental Education Shares Jumped Over 28%; Here Are 68 Biggest Movers From Yesterday
Gainers
ESSA Pharma Inc. (NASDAQ: EPIX) shares climbed 180.2% to close at $4.82 on Wednesday after the company highlighted updates results from the Phase 1/2 study of EPI-7386 with Enzalutamide At the 29th Annual Prostate Cancer Foundation Scientific Retreat.
Wingstop, Harley-Davidson, Rollins And Some Other Big Stocks Moving Higher On Wednesday
U.S. stocks traded mixed, with the Dow Jones gaining more than 200 points on Wednesday. Here are some big stocks recording gains in today’s session.